1. Home
  2. ASBP vs DPU Comparison

ASBP vs DPU Comparison

Compare ASBP & DPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

N/A

Current Price

$7.67

Market Cap

6.8M

Sector

Health Care

ML Signal

N/A

DPU

Top KingWin Ltd Class A Ordinary Shares

N/A

Current Price

$2.21

Market Cap

6.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
ASBP
DPU
Founded
2021
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
6.8M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ASBP
DPU
Price
$7.67
$2.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.3K
9.1K
Earning Date
04-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$1.62
52 Week High
$8.17
$2.60

Technical Indicators

Market Signals
Indicator
ASBP
DPU
Relative Strength Index (RSI) 58.00 59.06
Support Level $4.44 $1.72
Resistance Level $8.11 N/A
Average True Range (ATR) 0.59 0.22
MACD 0.02 0.05
Stochastic Oscillator 85.55 75.51

Price Performance

Historical Comparison
ASBP
DPU

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Share on Social Networks: